Bucindolol

Bucindolol
Clinical data
ATC code none
Identifiers
CAS Number 71119-11-4
PubChem (CID) 51045
ChemSpider 46266
UNII E9UO06K7CE YesY
ChEMBL CHEMBL2107546
ECHA InfoCard 100.114.291
Chemical and physical data
Formula C22H25N3O2
Molar mass 363.45 g/mol

Bucindolol is a non-selective beta blocker with additional weak alpha-blocking properties and some intrinsic sympathomimetic activity.[1][2] It was under review by the FDA in the United States for the treatment of heart failure in 2009, but was rejected due to issues pertaining to integrity of data submitted.[1][3]

See also

References


This article is issued from Wikipedia - version of the 6/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.